Mahima Datla is Managing Director of Biological E Limited. She directly oversees strategic operations within the organisation and leads the work related to public policy. She has been working with Biological E for the past 17 years and has served in various capacities across a diverse range of functions, including Biotechnology & Projects, Operations and Strategic Business Development. Under Ms Datla’s leadership, Biological E has demonstrated growth, given the successful WHO pre-qualification and launch of the Pentavalent and JE vaccines.
Apart from Biological E, Ms Datla has served on the steering committee of DCVMN (Developing Countries Vaccine Manufacturers Network) and is currently the President of the network. She is a member of FICCI (Federation of Indian Chambers of Commerce and Industry) and CII (Confederation of Indian Industry) National Biotech committees in India. She is currently a board member of the Global Health Innovative Technology fund – a Japanese government innovation healthcare fund for improving global access to healthcare. She is a member of the Board of Directors of the Sadhikaratha Foundation. She is also a member of the Life Sciences Advisory Committee formed by the Government of Telangana, India. Ms Datla was previously on the Board of Gavi from 2011 to 2014.
She holds a graduate degree in Business Administration Management from Webster University, London (UK).